Home/Filings/4/0001104659-22-095384
4//SEC Filing

ALTOMARI ALFRED 4

Accession 0001104659-22-095384

CIK 0001261249other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 8:30 AM ET

Size

5.1 KB

Accession

0001104659-22-095384

Insider Transaction Report

Form 4
Period: 2022-08-26
ALTOMARI ALFRED
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-08-26$0.45/sh+50,000$22,50064,343 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4467 to $0.4498, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

AGILE THERAPEUTICS INC

CIK 0001261249

Entity typeother

Related Parties

1
  • filerCIK 0001285644

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 8:30 AM ET
Size
5.1 KB